This undiscovered CBD play is on the verge of disrupting the industry
With recent health Canada approval they are poised to explode
Read more here

SELB Insider Trading (Selecta Biosciences)

Insider Ownership Percentage: 22.40%
Insider Buying (Last 12 Months): $18,471,995.38
Insider Selling (Last 12 Months): $19,172.01

Selecta Biosciences Insider Trading History Chart

Selecta Biosciences Share Price & Price History

▼ -0.04 (-0.96%)
As of 02/24/2021 01:00 AM ET
Days: 30 | 90 | 365
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!

Selecta Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2020Peter G TraberInsiderBuy40,000$3.24$129,600.0040,000  
12/2/2020Carsten BrunnCEOSell3,323$3.35$11,132.05104,673  
10/22/2020Timothy A SpringerDirectorBuy1,770,204$2.63$4,655,636.527,293,625  
10/20/2020Timothy A SpringerDirectorBuy1,887,696$2.30$4,341,700.807,293,625  
10/16/2020Timothy A SpringerDirectorBuy218,196$2.42$528,034.327,293,625  
10/8/2020Timothy A SpringerDirectorBuy3,185,394$1.71$5,447,023.747,293,625  
10/6/2020Timothy A SpringerDirectorBuy2,000,000$1.68$3,360,000.007,293,625  
9/2/2020Carsten BrunnCEOSell3,364$2.39$8,039.9697,099  
3/17/2020Timothy C BarabeDirectorBuy5,000$2.00$10,000.0088,173  
12/2/2019Carsten BrunnCEOSell14,272$1.53$21,836.1685,186  
8/13/2019Timothy C BarabeDirectorBuy10,000$1.72$17,200.0017,492  
1/25/2019Amir NashatDirectorBuy1,166,666$1.50$1,749,999.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Selecta Biosciences (NASDAQ:SELB)

56.92% of Selecta Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Selecta Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
2/23/2021Principal Financial Group Inc.88,226$0.27M0.0%N/A0.082%
2/19/2021JPMorgan Chase & Co.993,845$3.01M0.0%+816.3%0.920%
2/17/2021Jane Street Group LLC13,896$42K0.0%-33.1%0.013%
2/17/2021Cetera Advisors LLC235,000$0.71M0.0%N/A0.218%
2/16/2021Orbimed Advisors LLC539,169$1.63M0.0%-74.3%0.499%
2/16/2021Squarepoint Ops LLC40,235$0.12M0.0%+21.2%0.037%
2/16/2021Morgan Stanley1,319,031$4M0.0%+9,916.9%1.221%
2/16/2021Armistice Capital LLC1,636,000$4.96M0.2%N/A1.514%
2/16/2021Endurant Capital Management LP990,563$3M1.1%-34.5%0.917%
2/16/2021Nuveen Asset Management LLC402,173$1.22M0.0%+47.4%0.372%
2/16/2021Kingsview Wealth Management LLC11,400$35K0.0%N/A0.011%
2/16/2021ExodusPoint Capital Management LP25,568$77K0.0%N/A0.024%
2/16/2021Charles Schwab Investment Management Inc.192,747$0.59M0.0%+3.9%0.178%
2/12/2021Laurion Capital Management LP100,000$0.30M0.0%N/A0.093%
2/12/2021Public Employees Retirement System of Ohio66,631$0.20M0.0%N/A0.062%
2/12/2021Credit Suisse AG20,560$62K0.0%N/A0.019%
2/12/2021Virtus ETF Advisers LLC93,655$0.28M0.1%-18.6%0.087%
2/11/2021Northern Trust Corp798,900$2.42M0.0%-1.0%0.740%
2/11/2021Barclays PLC59,001$0.18M0.0%-22.8%0.055%
2/11/2021Citigroup Inc.17,001$52K0.0%+319.0%0.016%
2/11/2021Dynamic Technology Lab Private Ltd14,539$44K0.0%N/A0.013%
2/10/2021Rhumbline Advisers71,018$0.22M0.0%+16.2%0.066%
2/10/2021Renaissance Technologies LLC971,233$2.94M0.0%+95.7%0.899%
2/9/2021Wells Fargo & Company MN115,574$0.35M0.0%-27.4%0.107%
2/9/2021Advisory Services Network LLC10,000$30K0.0%+2,400.0%0.009%
2/9/2021Bank of New York Mellon Corp219,577$0.67M0.0%+7.1%0.203%
2/9/2021ProShare Advisors LLC31,696$96K0.0%N/A0.029%
2/8/2021Alliancebernstein L.P.98,500$0.30M0.0%-33.8%0.091%
2/8/2021New York State Common Retirement Fund28,300$86K0.0%-54.4%0.026%
2/8/2021Russell Investments Group Ltd.124,176$0.38M0.0%+1,387.5%0.115%
2/5/2021BlackRock Inc.5,474,324$16.59M0.0%+24.0%5.067%
2/5/2021SG Americas Securities LLC15,879$48K0.0%N/A0.015%
2/5/2021CM Management LLC325,000$0.99M0.9%N/A0.301%
2/4/2021GSA Capital Partners LLP61,145$0.19M0.0%N/A0.057%
2/4/2021State of Wisconsin Investment Board94,200$0.29M0.0%N/A0.087%
1/29/2021Asset Management Corp IL ADV30,000$0.11M0.1%N/A0.028%
1/20/2021Wealthstreet Investment Advisors LLC37,000$0.11M0.0%+64.4%0.034%
12/11/2020Virtu Financial LLC12,565$31K0.0%-53.2%0.012%
11/17/2020Jane Street Group LLC20,774$51K0.0%-87.7%0.019%
11/16/2020Point72 Asset Management L.P.400,000$0.99M0.0%-60.0%0.370%
11/16/2020AQR Capital Management LLC299,648$0.74M0.0%N/A0.277%
11/16/2020Squarepoint Ops LLC33,199$82K0.0%N/A0.031%
11/16/2020Mangrove Partners5,786,580$9.49M1.2%-11.6%5.356%
11/13/2020Morgan Stanley13,168$32K0.0%-91.5%0.012%
11/13/2020Vivo Capital LLC947,175$2.35M0.1%-58.0%0.877%
11/13/2020Charles Schwab Investment Management Inc.185,546$0.46M0.0%+15.4%0.172%
11/13/2020Virtus ETF Advisers LLC115,016$0.29M0.1%-12.0%0.106%
11/12/2020JPMorgan Chase & Co.108,464$0.28M0.0%+375.6%0.100%
11/12/2020Arrowstreet Capital Limited Partnership69,503$0.17M0.0%-57.8%0.064%
11/11/2020Wasatch Advisors Inc.2,069,757$5.13M0.0%-15.2%1.932%
11/10/2020State Street Corp1,184,555$2.94M0.0%+5.6%1.106%
11/9/2020Verdence Capital Advisors LLC16,000$40K0.0%N/A0.015%
11/9/2020Victory Capital Management Inc.14,137$35K0.0%N/A0.013%
11/6/2020BlackRock Inc.4,415,261$10.95M0.0%+11.6%4.121%
11/5/2020California Public Employees Retirement System145,000$0.36M0.0%+5.7%0.135%
11/5/2020Wells Fargo & Company MN159,186$0.39M0.0%+26.5%0.149%
10/30/2020BNP Paribas Arbitrage SA16,353$41K0.0%+542.3%0.015%
9/15/2020Two Sigma Advisers LP307,700$0.87M0.0%+187.8%0.287%
9/15/2020Schonfeld Strategic Advisors LLC50,500$0.14M0.0%N/A0.047%
8/25/2020Nuveen Asset Management LLC271,458$0.77M0.0%N/A0.253%
8/24/2020FMR LLC2,515,686$7.15M0.0%N/A2.348%
8/20/2020Charles Schwab Investment Management Inc.160,841$0.46M0.0%+997.1%0.150%
8/17/2020Jacobs Levy Equity Management Inc.242,187$0.69M0.0%+580.0%0.226%
8/17/2020Jane Street Group LLC168,488$0.48M0.0%+60.4%0.157%
8/17/2020Cerity Partners LLC20,000$57K0.0%N/A0.019%
8/17/2020Ironwood Investment Management LLC200,588$0.57M0.4%+142.0%0.187%
8/14/2020Orbimed Advisors LLC2,093,869$5.95M0.1%-19.3%1.954%
8/14/2020Man Group plc143,343$0.41M0.0%+271.1%0.134%
8/14/2020Point72 Asset Management L.P.1,000,000$2.84M0.0%+15.8%0.933%
8/14/2020Bank of America Corp DE66,402$0.19M0.0%-47.3%0.062%
8/14/2020Artal Group S.A.2,900,000$8.24M0.2%-15.0%2.707%
8/14/2020BVF Inc. IL8,294,547$23.56M1.5%+129.8%7.742%
8/14/2020Driehaus Capital Management LLC600,000$1.70M0.0%+140.0%0.560%
8/14/2020Mangrove Partners6,546,780$18.59M4.5%+18.0%6.110%
8/13/2020FMR LLC2,515,686$7.15M0.0%N/A2.348%
8/13/2020Marshall Wace North America L.P.2,852,704$8.10M0.1%N/A2.663%
8/12/2020American International Group Inc.41,473$0.12M0.0%N/A0.039%
8/12/2020Algert Global LLC21,880$62K0.0%N/A0.020%
8/12/2020Goldman Sachs Group Inc.56,477$0.16M0.0%-40.8%0.053%
8/12/2020Wasatch Advisors Inc.2,440,057$6.93M0.1%-24.3%2.277%
8/12/2020Bank of New York Mellon Corp184,942$0.53M0.0%N/A0.173%
8/12/2020California Public Employees Retirement System137,200$0.39M0.0%N/A0.128%
8/7/2020State Board of Administration of Florida Retirement System25,210$72K0.0%N/A0.029%
8/7/2020Virtu Financial LLC26,864$76K0.0%N/A0.031%
8/7/2020New York State Common Retirement Fund62,000$0.18M0.0%N/A0.071%
8/5/2020Virtus ETF Advisers LLC130,696$0.37M0.2%N/A0.149%
8/4/2020Quantitative Systematic Strategies LLC41,267$0.12M0.0%+10.7%0.047%
7/31/2020UBS Group AG31,871$91K0.0%N/A0.036%
5/18/2020Vivo Capital LLC7,846,509$18.91M1.7%N/A8.968%
5/15/2020RA Capital Management L.P.870,633$2.10M0.1%N/A0.995%
5/15/2020Orbimed Advisors LLC2,593,869$6.25M0.1%-9.9%2.965%
5/15/2020Squarepoint Ops LLC98,914$0.24M0.0%N/A0.113%
5/15/2020Jane Street Group LLC105,053$0.25M0.0%N/A0.120%
5/15/2020Morgan Stanley21,636$52K0.0%+18.7%0.025%
5/15/2020Two Sigma Investments LP182,822$0.44M0.0%+293.4%0.209%
5/15/2020Two Sigma Advisers LP106,900$0.26M0.0%+43.5%0.122%
5/15/2020Ghost Tree Capital LLC1,725,000$4.16M1.1%+50.0%1.972%
5/15/2020Driehaus Capital Management LLC250,000$0.60M0.0%N/A0.286%
5/14/2020Geode Capital Management LLC285,683$0.69M0.0%+1.7%0.327%
5/14/2020Ironwood Investment Management LLC82,900$0.20M0.2%N/A0.095%
Data available starting January 2016

See Full Table
Selecta Biosciences logo
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its proprietary pipeline includes therapeutic enzymes, gene therapies, and other products and product candidates affected by undesired immune responses. The company's lead product is SEL-212 that has completed Phase II clinical trials for the treatment of chronic refractory gout. It also engages in the development of gene therapy product candidates that are in preclinical development for rare inborn errors of metabolism, including SEL-302, a therapy program for the treatment methylmalonic academia; and SEL-313, a product candidate to treat ornithine transcarbamylase deficiency. Selecta Biosciences, Inc. has license and collaboration agreements with Spark Therapeutics; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; BIND Therapeutics, Inc.; Asklepios BioPharmaceutical, Inc. Sarepta Therapeutics, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts.
Read More

Today's Range

Now: $4.14

50 Day Range

MA: $4.11

52 Week Range

Now: $4.14


1,780,419 shs

Average Volume

2,376,942 shs

Market Capitalization

$447.24 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Selecta Biosciences?

Selecta Biosciences' top insider investors include:
  1. Timothy A Springer (Director)
  2. Carsten Brunn (CEO)
  3. Timothy C Barabe (Director)
  4. Peter G Traber (Insider)

Who are the major institutional investors of Selecta Biosciences?

Selecta Biosciences' top institutional shareholders include:
  1. BlackRock Inc. — 5.07%
  2. Armistice Capital LLC — 1.51%
  3. Morgan Stanley — 1.22%
  4. JPMorgan Chase & Co. — 0.92%
  5. Endurant Capital Management LP — 0.92%
  6. Renaissance Technologies LLC — 0.90%

Which major investors are selling Selecta Biosciences stock?

During the last quarter, SELB stock was sold by these institutional investors:
  1. Orbimed Advisors LLC
  2. Endurant Capital Management LP
  3. Alliancebernstein L.P.
  4. Wells Fargo & Company MN
  5. New York State Common Retirement Fund
  6. Virtus ETF Advisers LLC
  7. Barclays PLC
  8. Northern Trust Corp

Which major investors are buying Selecta Biosciences stock?

During the last quarter, SELB stock was purchased by institutional investors including:
  1. Armistice Capital LLC
  2. Morgan Stanley
  3. BlackRock Inc.
  4. JPMorgan Chase & Co.
  5. Renaissance Technologies LLC
  6. CM Management LLC
  7. Cetera Advisors LLC
  8. Nuveen Asset Management LLC
During the last year, these company insiders have bought Selecta Biosciences stock:
  1. Timothy A Springer (Director)
  2. Carsten Brunn (CEO)
  3. Timothy C Barabe (Director)
Are you looking for the next great pet stock play?
Don't miss this opportunity as FRPT is already trading over 100 dollars per share!
Read more here about the next great pet stock!